Related Experiment Video
Updated: Jul 4, 2026
09:44
Development, Characterization, and Evaluation of CAGE-based Ionic Liquid Systems for Transdermal Delivery
Published on: September 26, 2025
Colloidal carriers for the enhanced delivery through the skin
1Department of Pharmacobiological Sciences, Faculty of Pharmacy, University Magna Graecia of Catanzaro, Campus Universitario, Viale Europa I, Germaneto (CZ), Italy.
Expert Opinion on Drug Delivery
|July 2, 2008
Summary
This review explores advanced drug delivery systems for enhanced dermal and transdermal diffusion. Vesicular and particulate systems show promise for improving drug transport through the skin.
Area of Science:
- Dermatology and Pharmaceutical Sciences
- Nanotechnology in Drug Delivery
Background:
- The skin serves as a vital protective barrier with sensory and immune functions.
- Skin's structure presents challenges for effective dermal and transdermal drug delivery.
- Recent advancements focus on modulating skin for improved bioactive passage.
Purpose of the Study:
- To review the current state of drug transport through the skin.
- To highlight the role of advanced drug delivery devices.
- To explore vesicular and particulate systems for enhanced diffusion.
Main Methods:
- Review of scientific literature on skin drug delivery.
- Analysis of vesicular systems including liposomes, Transfersomes, niosomes, and ethosomes.
- Examination of particulate systems for dermal/transdermal applications.
Main Results:
- Vesicular and particulate systems are key innovations in drug delivery.
- These systems offer tailored characteristics for specific drug delivery needs.
- Significant progress has been made in utilizing these systems for improved drug efficacy.
Conclusions:
- Colloidal drug delivery systems are crucial for modern therapeutics.
- The diverse properties of these systems enable versatile applications.
- Further research in this area promises enhanced treatment outcomes.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:18Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:06Carrier-Mediated Transport
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
01:27Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
01:15Non-Oral Extravascular Drug Absorption Routes
Non-oral extravascular routes, which encompass sublingual, buccal, topical, intramuscular, and inhalation methods, primarily utilize passive diffusion to transport drugs into the systemic circulation. The absorption rates and effectiveness of these routes depend on the drug's physicochemical properties, as well as the patient's anatomical and pathophysiological state.
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more effectively...
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more effectively...